Form 4 for PASG Passage BIO, Inc.
Accepted 2023-08-01 00:00:00 ET · period of report 2023-07-28 · accession 0001209191-23-043998 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-01 | 2023-07-28 | PASG | King Simona | CFO | M - OptEx | $0.00 | +31.2K | 35.4K | +745% | $0 |
| D | 2023-08-01 | 2023-07-28 | PASG | King Simona | CFO | S - Sale+OE | $0.88 | -11.5K | 24.0K | -32% | -$10.1K |
| D | 2023-08-01 | 2023-07-28 | PASG | King Simona | CFO | M - OptEx | $0.00 | -31.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-28 | M | A | 31,250 | $0.00 | 35,447 | D | — | — | (F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2023-07-28 | S | D | 11,453 | $0.88 | 23,994 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-07-28 | M | D | 31,250 | $0.00 | 0 | D | — · — to — | 31,250 Common Stock | (F1) Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. (F3) Represents accelerated vesting of RSUs previously granted pursuant to the 2020 Equity Incentive Plan pursuant to a separation agreement between the Reporting Person and the Issuer. |